Biotech & Health

Samsung may invest in $100M round for medical imaging startup Exo

Biotech & Health /

Samsung’s venture investment unit is looking to invest in California-based medical device startup, Exo, in a round that could climb to $100 million, Bloomberg reported, citing anonymous sources. The round is being led by Sands Capital, Bold Capital and Qubit Health Capital, the report said, adding that Qubit’s chairman, Imar Ishrak, would join Exo’s board. […]

Samsung may invest in $100M round for medical imaging startup Exo Read More »

Hinge Health pops 17%, but joins growing ranks of down round IPOs

Biotech & Health /

Hinge Health, a digital physical therapist company, closed its first day of trading on the New York Stock Exchange on Thursday at $37.56, up about 17% over the $32 IPO price it set the previous day. That’s a good first-day result. But even with the pop, Hinge’s public valuation is significantly less than its last

Hinge Health pops 17%, but joins growing ranks of down round IPOs Read More »

Up to $900 off your ticket and 90% off for your +1 at Disrupt 2025

Biotech & Health /

Here’s the deal: Only 4 days left to save up to $900 on your TechCrunch Disrupt 2025 ticket — and an additional 90% off for your +1. From October 27–29, San Francisco’s Moscone West transforms into the epicenter of tech innovation as 10,000 tech, startup, and VC leaders gather for the 20th anniversary of TechCrunch

Up to $900 off your ticket and 90% off for your +1 at Disrupt 2025 Read More »

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M

Biotech & Health /

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction.  Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. The pharma giant said it plans to use the 23andMe customer data

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M Read More »

Fieldstone Bio is building microbes that can sense everything from TNT to arsenic

Biotech & Health /

The world is awash in data about, well, the world — thanks to satellites and environmental sensors. But there’s still a lot we can’t see, and Fieldstone Bio thinks microbes can change that. “They’ve evolved to sense and respond to information. It’s just trillions of calculations going on at all times all around us,” Brandon

Fieldstone Bio is building microbes that can sense everything from TNT to arsenic Read More »

Sprinter Health raises $55M to expand its at-home healthcare service

Biotech & Health /

When Max Cohen and Cameron Behar set out to launch a startup together during the pandemic, they decided to focus on the most top-of-mind sector of the era: healthcare. But since neither Cohen nor Behar had a background in healthcare (both worked at Google and Facebook previously), they had to think long and hard about

Sprinter Health raises $55M to expand its at-home healthcare service Read More »

Radiologists aren’t going anywhere | TechCrunch

Biotech & Health /

Nine years ago, AI pioneer Geoffrey Hinton sent shock waves through medicine by declaring it “just completely obvious” that AI would make radiologists extinct in short order. Fast-forward and the specialists — who do more than analyze images — are thriving, observes The New York Times. In fact, the field is experiencing explosive growth amid

Radiologists aren’t going anywhere | TechCrunch Read More »

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

Biotech & Health /

23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file claims as part of the restructuring process. The company and 11 of its subsidiaries, including Lemonaid Health and LPRXOne, filed for bankruptcy protection on

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14 Read More »

Fitness tracker Whoop faces unhappy customers over upgrade policy

Biotech & Health /

Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0 this week, it said members who wanted the new device could either extend their subscriptions by 12 months or pay a one-time upgrade fee of $49 ($79 for the model with EKG

Fitness tracker Whoop faces unhappy customers over upgrade policy Read More »

Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup

Biotech & Health /

Billy Evans, partner of Theranos founder Elizabeth Holmes, is working on a new startup that seeks to deliver “human health optimization” through blood testing, according to The New York Times. The Times reportedly spoke to two investors pitched on the startup, called Haemanthus, and also viewed some of Haemanthus’ marketing materials. In those materials, the

Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup Read More »